|
[1] YANG JD,HAINAUT P,GORES GJ,et al. A global view of hepatocellular carcinoma:Trends,risk,prevention and management[J]. Nat Rev Gastroenterol Hepatol,2019,16(10):589-604.
|
|
[2] KOPUSTINSKIENE DM,JAKSTAS V,SAVICKAS A,et al. Flavonoids as anticancer agents[J]. Nutrients,2020,12(2):457.
|
|
[3] ZHAO X,ZHANG J. Inhibitory effect of galangin on DNA topoisomerases in lung cancer cells[J]. J Cent South Univ(Med Sci),2015,40(5):479-485.(in Chinese)赵欣，张健．高良姜素对肺癌肿瘤细胞DNA拓扑异构酶的抑制及细胞杀伤作用[J]．中南大学学报(医学版)，2015,40(5):479-485.
|
|
[4] XU YF,YAO X. Inhibitory effect and mechanism of galangin on breast cancer metastasis[J]. Chin Tradit Herb Drug,2016,47(10):1731-1739.(in Chinese)许奕夫，姚鑫．高良姜素抑制乳腺癌转移作用机制研究[J]．中草药，2016,47(10):1731-1739.
|
|
[5] LEI D,ZHANG F,YAO D,et al. Galangin increases ERK1/2phosphorylation to decrease ADAM9 expression and prevents invasion in A172 glioma cells[J]. Mol Med Rep,2018,17(1):667-673.
|
|
[6] ZHOU YH,WEI JF,LI GD,et al. Warburg effect on tumor[J]. J Int Oncol,2017,44(10):762-766.(in Chinese)周宇会，魏九峰，李国东，等．Warburg效应在肿瘤中的研究进展[J]．国际肿瘤学杂志，2017,44(10):762-766.
|
|
[7] WANG Y,LIN B,LI H,et al. Galangin suppresses hepatocellular carcinoma cell proliferation by reversing the Warburg effect[J]. Biomed Pharmacother,2017,95:1295-1300.
|
|
[8] GWAK J,OH J,CHO M,et al. Galangin suppresses the proliferation ofβ-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase-3β-independentβ-catenin degradation[J]. Mol Pharmacol,2011,79(6):1014-1022.
|
|
[9] MARQUARDT JU,EDLICH F. Predisposition to apoptosis in hepatocellular carcinoma:From mechanistic insights to therapeutic strategies[J]. Front Oncol,2019,9:1421.
|
|
[10] LI Y,WANG ZX,WEN H,et al. Endoplasmic reticulum stress signaling pathway and its association with liver diseases[J]. J Clin Hepatol,2020,36(2):464-467.(in Chinese)李姚，王志鑫，温浩，等．内质网应激的信号通路及其与肝脏疾病的关系[J]．临床肝胆病杂志，2020,36(2):464-467.
|
|
[11] SU L,CHEN X,WU J,et al. Galangin inhibits proliferation of hepatocellular carcinoma cells by inducing endoplasmic reticulum stress[J]. Food Chem Toxicol,2013,62:810-816.
|
|
[12] ZHANG HT,LUO H,WU J,et al. Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway[J]. World J Gastroenterol,2010,16(27):3377-3384.
|
|
[13] JIANG W,WU DB,FU SY,et al. Insight into the role of TRAIL in liver diseases[J]. Biomed Pharmacother,2019,110:641-645.
|
|
[14] ZHANG HT,WU J,WEN M,et al. Galangin induces apoptosis in hepatocellular carcinoma cells through the caspase 8/tBid mitochondrial pathway[J]. J Asian Nat Prod Res,2012,14(7):626-633.
|
|
[15] AKULA SM,ABRAMS SL,STEELMAN LS,et al. RAS/RAF/MEK/ERK,PI3K/PTEN/AKT/m TORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma[J].Expert Opin Ther Targets,2019,23(11):915-929.
|
|
[16] LIU Y,MEI XF,WANG J,et al. Influence of galangin on the apoptosis of human hepatoma cells SMMC-7721 throughPI3K/AKT signal pathway[J]. Pharmocol Clin Chin Mater Med,2014,30(1):40-42.(in Chinese)刘影，梅晰凡，王晶，等．高良姜素对人肝癌SMMC-7721细胞PI3K/AKT信号通路的影响[J]．中药药理与临床，2014,30(1):40-42.
|
|
[17] YANG S,YANG L,LI X,et al. New insights into autophagy in hepatocellular carcinoma:Mechanisms and therapeutic strategies[J]. Am J Cancer Res,2019,9(7):1329-1353.
|
|
[18] WANG Y,WU J,LIN B,et al. Galangin suppresses HepG2cell proliferation by activating the TGF-βreceptor/Smad pathway[J]. Toxicology,2014,326:9-17.
|
|
[19] ZHANG H,LI N,WU J,et al. Galangin inhibits proliferation of HepG2 cells by activating AMPK via increasing the AMP/TAN ratio in a LKB1-independent manner[J]. Eur J Pharmacol,2013,718(1-3):235-244.
|
|
[20] WANG JY,LI SW,GONG JP,et al. Role of silent information regulator 1 in hepatic ischemia-reperfusion injury[J]. J Clin Hepatol,2019,35(6):1388-1391.(in Chinese)王敬元，李生伟，龚建平，等．沉默信息调节因子1在肝脏缺血再灌注损伤中的作用[J]．临床肝胆病杂志，2019,35(6):1388-1391.
|
|
[21] LI X,WANG Y,XIONG Y,et al. Galangin induces autophagy via deacetylation of LC3 by SIRT1 in HepG2 cells[J]. Sci Rep,2016,6:30496.
|
|
[22] WEN M,WU J,LUO H,et al. Galangin induces autophagy through upregulation of p53 in HepG2 cells[J]. Pharmacology,2012,89(5-6):247-255.
|
|
[23] LI J,XIAO D,LI ZQ,et al. Expression and significance of matrix metalloproteinase 9 gene in hepatocellular carcinoma cell lines and hepatocellular carcinoma tissues[J]. Chin J Public Health Eng,2018,17(3):351-353.(in Chinese)李杰，肖达，李智奇，等．基质金属蛋白酶9基因在肝癌细胞株、肝细胞肝癌组织中的表达及意义[J]．中国卫生工程学，2018,17(3):351-353.
|
|
[24] CHIEN ST,SHI MD,LEE YC,et al. Galangin,a novel dietary flavonoid,attenuates metastatic feature via PKC/ERK signaling pathway in TPA-treated liver cancer HepG2 cells[J].Cancer Cell Int,2015,15:15.
|
|
[25] FODOR D,JUNG I,TURDEAN S,et al. Angiogenesis of hepatocellular carcinoma:An immunohistochemistry study[J].World J Hepatol,2019,11(3):294-304.
|
|
[26] HUANG H,CHEN AY,ROJANASAKUL Y,et al. Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis[J]. J Funct Foods,2015,15:464-475.
|
|
[27] KASEB AO,HANBALI A,COTANT M,et al. Vascular endothelial growth factor in the management of hepatocellular carcinoma:A review of literature[J]. Cancer,2009,115(21):4895-4906.
|
|
[28] YE Q,LIU K,SHEN Q,et al. Reversal of Multidrug resistance in cancer by multi-functional flavonoids[J]. Front Oncol,2019,9:487.
|
|
[29] ZHU X,WONG I,CHAN KF,et al. Triazole bridged flavonoid dimers as potent,nontoxic,and highly selective breast cancer resistance protein(BCRP/ABCG2)inhibitors[J]. J Med Chem,2019,62(18):8578-8608.
|
|
[30] REN K,ZHANG W,WU G,et al. Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells[J].Biomed Pharmacother,2016,84:1748-1759.
|
|
[31] YU S,GONG LS,LI NF,et al. Galangin(GG)combined with cisplatin(DDP)to suppress human lung cancer by inhibition of STAT3-regulated NF-κB and Bcl-2/Bax signaling pathways[J]. Biomed Pharmacother,2018,97:213-224.
|
|
[32] PATIL S,UJALAMBKAR V,RATHORE A,et al. Galangin loaded galactosylated pluronic F68 polymeric micelles for liver targeting[J]. Biomed Pharmacother,2019,112:108691.
|
DownLoad: